UBM hives off Belgian medical print activities into JV
Business events organiser and publisher UBM is hooking up with Belgian-French publishing and printing firm Roularta Media to form a medical print journal joint venture.
Business events organiser and publisher UBM is hooking up with Belgian-French publishing and printing firm Roularta Media to form a medical print journal joint venture.
UBM Medica and Roularta have merged their respective Belgian professional medical print businesses into ActuaMedica, a 50:50 joint venture company.
The staff and assets relating to UBM Medica's print and digital titles will be combined, as will the prescription pads business of both companies. The joint venture company will retain the rights to publish the Medex directory under licence. ActuaMedica will have its headquarters in Roularta's offices in Brussels.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
UBM stressed it remains committed to the Belgium medical market through its continued 100% ownership of its digital data businesses in Belgium (Medibridge and drug information systems), as well as its
50% equity interest in ActuaMedica.
"ActuaMedica is well placed to prosper in both print and digital as the media market evolves. In parallel we will continue to to build our wholly-owned Belgian data business as part of our UBM Medica EMEA [Europe, Middle East and Africa] operations," said Henry Elkington, Chief Executive Officer of UBM Medica.
jh
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
-
Energy bills to rise by 1.2% in January 2025
Energy bills are set to rise 1.2% in the New Year when the latest energy price cap comes into play, Ofgem has confirmed
By Dan McEvoy Published
-
Should you invest in Trainline?
Ticket seller Trainline offers a useful service – and good prospects for investors
By Dr Matthew Partridge Published